For instance, elevated tau expression in a number of carcinoma types, including gliomas, breast cancer, and prostate cancer, has been associated with better patient outcomes [66,70,71], while it appears to be related to a lower prognosis in other cancer forms, like ovarian cancer [72,73]. This evidence concerns the gene MAPT and Familial prostate cancer.